NCT07058493View on ClinicalTrials.gov

Dexmedetomidine as an Additive for (Ipack)Block in Knee Surgery

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 2, 2024

Primary Completion Date

July 10, 2024

Study Completion Date

July 30, 2024

Conditions
Knee Surgeries
Interventions
DRUG

Dexmedetomidine

dexmedetomidine 100 μg as adjuvant to IPACK block with 20 ml of bupivacaine 0.25%.

DRUG

Bupivacaine

20 ml of bupivacaine 0.25%.

Trial Locations (1)

Unknown

Faculty of medicine Cairo university, Cairo

All Listed Sponsors
lead

Cairo University

OTHER

NCT07058493 - Dexmedetomidine as an Additive for (Ipack)Block in Knee Surgery | Biotech Hunter | Biotech Hunter